Korean Pharmaceutical Association
Established in 1928, Korean Pharmaceutical Association (KPA), which consists of approximately 80,000 members, has worked continuously for over 90 years to improve public health and pharmaceutical sciences, and to expand the role of pharmacists by actively engaging in various fields. Confronting diverse challenges under the current Pharmaceutical Affairs Act, KPA is recently focusing on revising policies and laws under the slogan: ‘Prescription Drugs: Public Goods, Public Responsibility’ and pursue changes in institutions, laws, and policies that obstruct pharmacists from properly contributing to the improvement of national health.
Seoul Metropolitan Government
The Seoul Tourism Foundation is attempting not only overseas marketing projects in the fields of tourism and MICE, but also new businesses that accompany Seoul citizens and the tourism industry in Seoul. In order to enhance the status of the international tourist city of Seoul, They are exploring unique tourism contents of Seoul and conducting global marketing. It also supports events including related international conferences.
Korea Tourism Organization
Korea Tourism Organization has a mission to lead tourism as a future growth engine and contribute to improving the quality of people’s lives. They carry out various projects leading the tourism industry by taking the growth of local tourism, securing high quality tourism competitiveness, expanding the convergence of tourism industry, and creating social values as four major strategic directions.
International Federation of Pharmaceutical Manufacturers & Associations
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Hanmi Pharmaceutical Company
Hanmi jumps up to be a global leading pharmaceutical company with the development of new biologics, new chemical entities, and innovative new drugs.
Hanmi’s first mission, ‘respect for human life, value creation’, is creating new values to keep everyone’s health and improve their quality of life. Based on this management philosophy, Hanmi makes an effort to be a healthy social corporation developing a business model that contributes to human health.
SO & COMPANY Inc. is a unique medical communication company that possesses the strength in strategic excellence and information design since 2015. With the big wave of digitalization within the healthcare market, SO & COMPANY Inc. is transforming to be the best mixologist of the digital and strategy based on its strength and experience.
Taejeon Group is a leading pharmaceutical distribution company in Korea with 80 years of history. They have a vision to provide their customers with Total Health Care products and information and to provide lifelong learning. Recently, they’ve been offering a drugstore platform called HAHAHA Alliance, which has a new impact on the local pharmacies system market.
Handok Pharmaceutical Company
Since its establishment in 1954, HanDok pharmaceutical company has formed various partnerships with leading global pharmaceutical companies which is the first Korean pharmaceutical company to form a joint venture with Germany’s Hoechst. Recently, HanDok has developed a new drug based on the Open Innovation strategy. Furthermore, they have a roadmap to develop new materials and innovative products by linking the outstanding research capabilities of Korean and foreign research institutes and bio-venture companies.
GC Pharma, a biotechnology pioneer in South Korea, has persevered over the years with singlehearted dedication toward pain-free, happy lives for all. GC Pharma has pioneered, and zealously guard our expertise on, plasma and vaccine products. Challenge and innovation, care and compassion, transparency and integrity, and respect and dedication are the core principles that guide GC Pharma on its journey toward achieving its next goal.
In addition to having established nearly a dozen plasma centers in the United States, we have also opened a plasma fractionation factory in Canada, thus completing the basis for our expansion into the North American market. GC Pharma is the No. 1 provider of varicella and seasonal flu vaccines for international organizations. In the meantime, GC Pharma has been strengthening and innovating our R&D pipeline.
Korea Otsuka Pharmaceutical
Established in 1982, Korea Otsuka Pharmaceutical is a Japanese joint-stock corporation that provides excellent and innovative medicines and healthcare products to treat diseases, but also to maintain and improve the everyday health of Korean people. Korea Otsuka Pharmaceutical not only suppies products in South Korea, but also continually expands the role as a production base for Otsuka Pharmaceutical. In addition, Korea Otsuka Pharmaceutical has taken the lead in improving South Korea’s clinical capabilities and share of the medical market by engaging in global clinical research & development activities. Korea Otsuka Pharmaceutical has been named an innovative pharmaceutical company in recognition of excellence in terms of R&D investment, domestic production operations, and overseas expansion.
Bio Marketing Lab
Based in Seoul, South Korea, Bio Marketing Lab is establised to inspire and develop global talents in the Healthcare industry by offering pharmaceutical marketing programs to people from healthcare industry. Bio Marketing Lab offers various courses such as Digital Marketing, Fundamental Marketing, Analytical Marketing, OTC Marketing, Multi Channel Marketing Workshops and etc. Since it is establihsed, Bio Marketing Lab has been collaborating with outside experts in various fields, including consulting, statistics, and big data analysts, to educate and support competent marketers in pharmaceutical fields.